Naltrexone Dosage and Duration for Alcohol Use Disorder
For alcohol use disorder treatment, naltrexone should be administered at 50 mg once daily for 3-12 months, with treatment discontinuation if a 5% reduction in body weight is not achieved after 12 weeks of therapy. 1, 2
Dosing Protocol
Initial Dosing
- Start with 25 mg for the first 1-3 days to assess tolerability 3
- Increase to standard maintenance dose of 50 mg once daily 1, 3
Alternative Dosing Regimens
- For supervised administration: 100 mg Monday/Wednesday and 150 mg Friday 2, 1
- Injectable extended-release formulation: 380 mg monthly (alternative to daily oral dosing) 2
- Higher doses (150 mg/day) have been studied in patients with prominent alcohol cravings with promising results, but are not standard practice 4
Duration of Treatment
- Standard duration: 3-6 months 3
- May extend up to 12 months in selected cases 3, 1
- Discontinue if patient has not achieved at least 5% reduction in drinking after 12 weeks on maintenance dose 3
Patient Selection and Preparation
Ensure patient is opioid-free before starting treatment
Best candidates for naltrexone therapy:
- Motivated patients
- Those with stable social support
- Employed individuals
- Married patients 2
Monitoring Protocol
- Baseline liver function tests before initiating therapy 2
- Follow-up liver function tests every 3-6 months 2
- Assess treatment response at 12 weeks; if no significant reduction in drinking (less than 5% reduction), consider discontinuation 3
- Monitor for side effects, particularly:
Efficacy and Outcomes
- When combined with psychosocial interventions, naltrexone reduces relapse rates by approximately 50% compared to placebo 5, 7
- Approximately 27% of patients receiving naltrexone with cognitive coping skills therapy maintain complete abstinence from heavy drinking, compared to only 3% with placebo 8
- Naltrexone works by:
Important Precautions
Contraindicated in patients with:
- Current opioid use or dependence
- Acute hepatitis or liver failure
- Need for opioid pain management 2
Naltrexone is not hepatotoxic at the recommended 50 mg/day dosage for alcohol dependence 5, but caution is advised in patients with liver disease
- In patients with moderate to severe hepatic impairment, total daily dose should not exceed 1 tablet daily 3
Discontinue before procedures requiring opioid analgesia 3
Integration with Comprehensive Treatment
Naltrexone should be used as part of a comprehensive treatment approach that includes:
- Psychosocial interventions (cognitive behavioral therapy, motivational enhancement therapy)
- Community-based support groups
- Regular follow-up to ensure medication compliance 2, 6
Naltrexone is not aversive therapy and does not cause a disulfiram-like reaction with alcohol consumption 1. It is most effective when combined with behavioral interventions that enhance medication compliance 1, 7.